p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect

被引:142
作者
Blagosklonny, MV [1 ]
机构
[1] NCI, Med Branch, NIH, Bethesda, MD 20892 USA
关键词
prion; dysfunction; cancer therapy; trans-activating function;
D O I
10.1096/fj.99-1078rev
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increasing the complexity of their models, p53s are stabilized either in order to function (wt p53) or due to the loss of function (mutant p53) with acquiring a mysterious prion-like ability to drive the normal p53 into the abnormal conformation to gain new functions. As already recognized, the loss of trans-activating function leads to a stabilization of mutant p53 because of the disappearance of the p53-inducible proteins, which otherwise directly (Mdm-2) or indirectly (p21) target p53 for degradation. Simplifying further, I will discuss that the loss of function results in a dominant-negative effect and gain-of-function (a dominant-positive effect). Thus, mutant p53 lacking trans-activation function nevertheless may retain the ability to repress transcription due to its competition with numerous transcription factors for their coactivators. When mutant p53 competes with wt p53, the inhibition of the wt p53-dependent transcription is perceived as a dominant-negative effect. Just like trans-repression, a dominant-negative effect requires an excess of p53 and, therefore, a 'dominant'-negative effect is not dominant. Furthermore, the stabilization of an endogenous mt p53 due to the loss of wt functions cannot occur in the presence of the wt p53 allele. Given the inability of mutant p53 to accumulate in the presence of wt p53, a dominant-negative effect does not naturally occur and, not surprisingly, heterozygous mt/wt cells are rare. The detection of a dominant-negative effect simply indicates that mutant p53 indeed has lost its function. Last, since mutant p53 loses some or most but not all activities and accumulates in the absence of wt allele, gain-of-function can be considered as an exaggeration of the remaining functions. Applications to cancer therapy are discussed.
引用
收藏
页码:1901 / 1907
页数:7
相关论文
共 92 条
  • [41] Haupt Ygal, 1997, Leukemia (Basingstoke), V11, P337
  • [42] Tumour associated mutants of p53 can inhibit transcriptional activity of p53 without heterooligomerization
    Joers, A
    Kristjuhan, A
    Kadaja, L
    Maimets, T
    [J]. ONCOGENE, 1998, 17 (18) : 2351 - 2358
  • [43] LOSS OF HETEROZYGOSITY ON CHROMOSOME-17P AND MUTANT P53 IN HPV-NEGATIVE CERVICAL CARCINOMAS
    KAELBLING, M
    BURK, RD
    ATKIN, NB
    JOHNSON, AB
    KLINGER, HP
    [J]. LANCET, 1992, 340 (8812) : 140 - 142
  • [44] A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY UTILIZING P53 AND GADD45 IS DEFECTIVE IN ATAXIA-TELANGIECTASIA
    KASTAN, MB
    ZHAN, QM
    ELDEIRY, WS
    CARRIER, F
    JACKS, T
    WALSH, WV
    PLUNKETT, BS
    VOGELSTEIN, B
    FORNACE, AJ
    [J]. CELL, 1992, 71 (04) : 587 - 597
  • [45] P53, CELL-CYCLE CONTROL AND APOPTOSIS - IMPLICATIONS FOR CANCER
    KASTAN, MB
    CANMAN, CE
    LEONARD, CJ
    [J]. CANCER AND METASTASIS REVIEWS, 1995, 14 (01) : 3 - 15
  • [46] ONCOGENIC FORMS OF P53 INHIBIT P53-REGULATED GENE-EXPRESSION
    KERN, SE
    PIETENPOL, JA
    THIAGALINGAM, S
    SEYMOUR, A
    KINZLER, KW
    VOGELSTEIN, B
    [J]. SCIENCE, 1992, 256 (5058) : 827 - 830
  • [47] MUTATION AND CHILDHOOD CANCER - PROBABILISTIC MODEL FOR INCIDENCE OF RETINOBLASTOMA
    KNUDSON, AG
    HETHCOTE, HW
    BROWN, BW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (12) : 5116 - 5120
  • [48] p53: Puzzle and paradigm
    Ko, LJ
    Prives, C
    [J]. GENES & DEVELOPMENT, 1996, 10 (09) : 1054 - 1072
  • [49] A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy
    Komarov, PG
    Komarova, EA
    Kondratov, RV
    Christov-Tselkov, K
    Coon, JS
    Chernov, MV
    Gudkov, AV
    [J]. SCIENCE, 1999, 285 (5434) : 1733 - 1737
  • [50] Regulation of p53 stability by Mdm2
    Kubbutat, MHG
    Jones, SN
    Vousden, KH
    [J]. NATURE, 1997, 387 (6630) : 299 - 303